Feed Top Reports Pricing

⌘K

00:15:07·1610d

SECFiling

SEC Form EFFECT filed by Flexion Therapeutics, Inc.

FLXN· Flexion Therapeutics, Inc.

Health Care

Original source

Companies

FLXN
Flexion Therapeutics, Inc.
Health Care

Recent analyst ratings

Nov 19UpdateNorthland Capital Markets-
Oct 19UpdateHC Wainwright & Co.$10.00
Oct 12UpdateBMO Capital$12.00
Oct 12UpdateRaymond James-
Oct 12UpdateCredit Suisse$10.00
Aug 6UpdateGoldman Sachs$6.00

Related

PR1408d
Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer
SEC1606d
SEC Form 15-12B filed by Flexion Therapeutics, Inc.
INSIDER1612d
SEC Form 4 filed by Newtyn Management, Llc
INSIDER1612d
SEC Form 3: New insider Newtyn Management, Llc claimed ownership of 5,900,000 shares
INSIDER1616d
SEC Form 4: Stejbach Mark returned $107,364 worth of shares to the company (12,631 units at $8.50), closing all direct ownership in the company to cover taxes
INSIDER1616d
SEC Form 4: Milinazzo Alan returned $233,325 worth of shares to the company (27,450 units at $8.50), closing all direct ownership in the company to satisfy withholding tax
INSIDER1616d
SEC Form 4: Merrifield C Ann returned $161,500 worth of shares to the company (19,000 units at $8.50), closing all direct ownership in the company to cover withholding tax
INSIDER1616d
SEC Form 4: Lukatch Heath returned $76,500 worth of shares to the company (9,000 units at $8.50), closing all direct ownership in the company to satisfy tax liability

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022